The Patent Finder
US

Method of Detecting TIM-3 Using Antibody Molecules to TIM-3

US 11,155,620 In force
OverviewFamilyAssignmentsSources & methods

Term ends Feb 20, 2035 · High confidence

Held by Novartis AG
Filed Sep 30, 2019 as application 16/588,063 · Granted Oct 26, 2021
Base term plus 21 days of patent term adjustment (USPTO delay)
Today
20 years from filing
2015 2035
Clock starts
Jan 30, 2015
Term ends
Feb 20, 2035
Granted
Oct 26, 2021
base term patent term adjustment fee events Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
21
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 21 days past its 20-year base term on prosecution delay. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jan 30, 2015, when application 14/610,837, the earliest non-provisional in its chain, was filed (this one was filed Sep 30, 2019)Jan 30, 2035High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+21 days, USPTO patent term adjustment recordFeb 20, 2035High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderFeb 20, 2035High confidence

This family

US 9,605,070In force
Jan 2035
Jan 2035
US 10,472,419In force
Jan 2035
Jan 2035
US 9,884,913In force
Jan 2035
Jan 2035
US 11,155,620this patent
Feb 2035
Feb 2035
US 10,981,990In force
Jan 2035
Jan 2035
Application 17/484,794Abandoned
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 15, 2020
Reel 51522, frame 161
Sabatos-peyton, Catherine Anne; Mataraza, Jennifer Marie; Blattler, Walter A.; Hicklin, Daniel J.Costim Pharmaceuticals Inc.Assignment of Assignor's Interest
Jan 15, 2020
Reel 51522, frame 210
Brannetti, Barbara; Huber, Thomas; Pietzonka, ThomasNovartis Pharma AGAssignment of Assignor's Interest
Jan 15, 2020
Reel 51522, frame 251
Harris, Alan S.Novartis Institutes for Biomedical Research, Inc.Assignment of Assignor's Interest
Jan 15, 2020
Reel 51522, frame 297
Hu, Tiancen; Taraszka, John A.; Xu, FangminNovartis Institutes for Biomedical Research, Inc.Assignment of Assignor's Interest
Jan 15, 2020
Reel 51522, frame 331
Freeman, Gordon JamesDana-Farber Cancer Institute, Inc.Assignment of Assignor's Interest
Jan 15, 2020
Reel 51522, frame 407
Dekruyff, Rosemarie H.; Umetsu, Dale T.Children's Medical Center CorporationAssignment of Assignor's Interest
Jan 15, 2020
Reel 51522, frame 456
Vasquez, MaximilianoGalaxy Biotech, LLCAssignment of Assignor's Interest
Jan 15, 2020
Reel 51522, frame 471
Galaxy Biotech, LLCCostim Pharmaceuticals Inc.Assignment of Assignor's Interest
Jan 15, 2020
Reel 51522, frame 504
Costim Pharmaceuticals Inc.Novartis AGAssignment of Assignor's Interest
Jan 15, 2020
Reel 51522, frame 518
Novartis Pharma AGNovartis AGAssignment of Assignor's Interest
Jan 15, 2020
Reel 51522, frame 531
Novartis Institutes for Biomedical Research, Inc.Novartis AGAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited